Articles, Blogs, News
310.ai and Arctoris Partner to Pioneer AI-Designed Proteins for Cardiac Therapy
What if AI could design a brand-new protein, from scratch, to tackle heart disease? That’s no longer science fiction. In…
Combining Mechanistic Enzymology, Precision Biochemical Experimentation and Simulation in Drug Discovery
Integrating mechanistic enzymology with precision experimentation techniques and streamlined data simulation capabilities brings new levels of detailed understanding to the…
Macrocycles! The next chapter in small molecule drug discovery?
Here’s why: 1️⃣ Shape-shifting Superstars: Macrocycles boast unique chemical properties that set them apart from conventional small molecules. Their grand…
Why Kinetics Matter
A lot of people asked me recently why kinetics in hashtag#drugdiscovery matter (mostly scientists, but some smart investors too! 🤓),…
Biotech 3.0: Data as the Catalyst for the Next Revolution in Drug Discovery
The integration of machine learning (ML) into small-molecule drug discovery has long been heralded as the game-changer that would bring…
Building the Future of Drug Discovery
Foundation Models and the Power of Proprietary Experimental Data In recent years, foundation models have revolutionised fields from natural language…
Arctoris’ automated platform accelerates drug discovery
Oxford-headquartered Arctoris progresses programmes from target to hit, lead, and candidate with superior efficiency, accuracy, and confidence. Key to the company’s capabilities is the unique…
Molecular glues – A sticky subject
Molecular glues are small molecules that can bind to two or more proteins, facilitating their interaction and potentially leading to…